What is the current market size?

The **cell separation technologies market size** reached USD 1.2 billion in 2023, driven by advancements in immunotherapy and regenerative medicine.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2032, with a **future outlook** exceeding USD 2 billion by 2032.

What are the key growth drivers?

Rising demand for personalized medicine, expansion of stem cell research, and automation in cell isolation processes are primary drivers.

What challenges does the market face?

High costs of advanced systems, technical complexity, and stringent regulatory compliance hinder widespread adoption of separation technologies.

Which regions lead the market?

North America dominates due to robust R&D, followed by Europe and Asia-Pacific, where rising biotech investments fuel growth.

Who are the top companies?

Leading firms include Thermo Fisher Scientific, Miltenyi Biotec, and Beckman Coulter, offering innovative centrifugation and flow cytometry solutions.

What future opportunities exist?

Emerging fields like single-cell analysis, AI-driven sorting, and point-of-care devices present untapped potential in the **cell separation technologies market**.

How is technology impacting the market?

Advances in microfluidics, magnetic bead separation, and automation are enhancing precision, scalability, and cost-efficiency in cell isolation.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA emphasize standardization for clinical-grade separation, increasing compliance costs but ensuring product safety.

cell separation technologies Market Intelligence Report 2026 — Updated June 2026

cell separation technologies by Application (Oncology Research, Neuroscience Research, Stem Cell Research, Microbiology and Immunology Research, Others), by Types (Gradient Centrifugation, Surface Markers Separation, Fluorescence Activated Cell Sorting, Magnetic Cell Sorting, Others) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

cell separation technologies Market Size | CAGR 12.3 Forecast 2033

cell separation technologies Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

cell separation technologies Market Overview

Cell separation technologies encompass methods and systems for isolating specific cell types from heterogeneous mixtures, critical for advancing applications in regenerative medicine, diagnostics, and therapeutic development. As the cell separation technologies market size expands with innovations in precision medicine and biopharma, stakeholders are focused on understanding the market forecast for 2026–2033 and industry expansion potential. The global market, valued at $1.2 billion in 2023, is projected to grow at a CAGR of 8.4% through 2033, driven by rising demand for cell-based therapies like CAR-T and stem cell treatments.

Loading chart…

Key forces shaping the cell separation technologies market include technological shifts toward automation and AI-driven data analytics, enhancing precision and scalability. Regulatory support for cell therapies and investments in single-cell sequencing infrastructure are also accelerating adoption. North America remains the largest regional market due to its advanced healthcare ecosystem, while Asia-Pacific is the fastest-growing region, fueled by low-cost manufacturing and government-backed biotech initiatives. Strategic collaborations between diagnostics players and biopharma firms will define competitive dynamics in the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	3.16 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Miltenyi Biotec GmbH; BD Bioscience; STEMCELL Technologies; Terumo BCT; PluriSelect GmbH; EMD Millipore; Life Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The cell separation technologies market is expanding due to the rising adoption of cell-based therapies in oncology and regenerative medicine. Innovations in cell separation technologies market size are being driven by the need for high-purity cell isolation to support advanced treatments like CAR-T and stem cell therapies.

Advancements in automation and artificial intelligence are enhancing the precision and scalability of cell separation systems. These technologies reduce manual errors and improve batch consistency, fueling growth forecast estimates for the cell separation technologies market through 2030.

Restraints2 items

High capital expenditures for advanced cell separation equipment, such as microfluidic platforms and laser-based sorters, limit accessibility for small biotech firms and emerging market players.

Stringent regulatory requirements for cell separation processes, particularly in clinical applications, delay product approvals and increase compliance costs.

Opportunities2 items

Expansion into untapped regions like Southeast Asia and Latin America, where healthcare infrastructure investments are accelerating, presents a significant growth avenue for the cell separation technologies market.

Development of cost-effective point-of-care cell separation devices could democratize access to personalized therapies, aligning with the market’s shift toward decentralized diagnostics and treatment models.

Challenges2 items

Technical limitations in separating heterogeneous cell populations with high viability rates remain a barrier, particularly for complex applications like organoid research and multiomic profiling.

Intense competition from alternative methods such as flow cytometry and magnetic-activated cell sorting (MACS) pressures margins and requires continuous R&D investment to differentiate offerings.

Market Segmentation

Loading chart…

Application segmentation in the cell separation technologies market is divided into therapeutic applications and research/diagnostics. Therapeutic applications, accounting for 52% of the market, focus on isolating specific cell populations for regenerative medicine, immunotherapy, and stem cell therapies. This segment drives demand due to the precision required in clinical-grade cell isolation. Conversely, research and diagnostics (48%) emphasize scalability and cost-effectiveness for academic studies, drug development, and disease diagnostics. The therapeutic segment's growth is fueled by rising personalized medicine adoption, while the research segment benefits from increasing preclinical studies. This cell separation technologies segmentation highlights divergent needs between clinical and non-clinical use cases.

Types segmentation includes density gradient centrifugation, magnetic cell sorting, and microfluidic devices. Density gradient centrifugation (35% market share) remains the most established method, leveraging buoyant density differences for bulk cell separation. Magnetic cell sorting (40%) dominates due to its high purity and scalability, particularly in isolating cells using antibody-conjugated magnetic beads. Microfluidic devices (25%), though niche, are gaining traction for their miniaturization and label-free separation capabilities, ideal for rare cell isolation. Each type addresses distinct challenges: centrifugation for cost-efficiency, magnetic sorting for functional enrichment, and microfluidics for precision. This taxonomy underscores technological evolution from traditional to advanced modalities.

cell separation technologies Segmentation Breakdown12 items

Application

Oncology Research

Neuroscience Research

Stem Cell Research

Microbiology and Immunology Research

Others

Types

Gradient Centrifugation

Surface Markers Separation

Fluorescence Activated Cell Sorting

Magnetic Cell Sorting

Others

Regional Insights

Loading chart…

The cell separation technologies market growth is dominated by North America, accounting for ~40% of global demand, driven by advanced healthcare infrastructure, high R&D investments, and a mature biotech ecosystem. The region benefits from robust policy frameworks, such as FDA approvals, and a surge in personalized medicine adoption. Meanwhile, the Asia Pacific region is the fastest-growing market, projected to expand at a CAGR exceeding 12% through 2030. Key drivers include rising government funding for regenerative medicine, a growing patient pool for oncology therapies, and collaborations between local manufacturers and global players.

Regional Drivers & Opportunities5 items

North America: High adoption of automation in cell separation, strong venture capital inflows, and a skilled R&D workforce.

Europe: Stringent regulatory standards (e.g., EMA guidelines), aging demographics boosting stem cell therapies, and cross-border research alliances.

Asia Pacific: Expansion of GMP-certified facilities, increasing incidence of chronic diseases, and cost-competitive manufacturing ecosystems.

Latin America: Rising healthcare infrastructure investments and partnerships with North American biotech firms.

Middle East & Africa: Emerging focus on precision medicine, supported by national health transformation programs and public-private partnerships.

The regional forecast underscores a shift toward Asia Pacific as a hub for innovation, while North America retains leadership in market maturity. Strategic partnerships and policy-driven adoption will shape the cell separation technologies market trajectory.

Competitive Landscape

The cell separation technologies market exhibits a moderately consolidated structure, with global players and regional specialists competing across diverse therapeutic and research applications. Strategic differentiation centers on product innovation, regulatory approvals, and partnerships to enhance distribution networks. The cell separation technologies competitive landscape is shaped by pricing pressures in commoditizing segments, offset by premium offerings in niche applications like CAR-T cell manufacturing. Key players prioritize ISO and FDA certifications as competitive barriers, while local firms leverage lower R&D costs to challenge incumbents in emerging markets.

Competitive strategies emphasize M&A to consolidate IP portfolios, joint ventures for clinical validation, and localized manufacturing to mitigate supply chain risks. Differentiation emerges through proprietary separation algorithms, closed-system automation, and customizable workflows for biobanking. A key challenge is balancing R&D investments against margin compression from pricing competition in diagnostic applications. Strategic alignment with CROs and biopharma clients further strengthens channel control, with compliance costs in single-use system regulations acting as an entry barrier.

Miltenyi Biotec GmbH: Innovation pipeline in magnetic separation platforms

BD Bioscience: OEM tie-ups for automated cell isolation systems

STEMCELL Technologies: Niche R&D for stem cell enrichment solutions

Terumo BCT: Regional expansion in Asia-Pacific biobanking markets

PluriSelect GmbH: Premium pricing for recombinant antibody-based kits

EMD Millipore: Vertical integration of filtration and separation solutions

Key cell separation technologies Companies7 items

Miltenyi Biotec GmbH

BD Bioscience

STEMCELL Technologies

Terumo BCT

PluriSelect GmbH

EMD Millipore

Life Technologies

Market Ecosystem

The cell separation technologies ecosystem spans upstream raw material sourcing, midstream technology development, and downstream application deployment. Value is generated through specialized components, integration into separation systems, and adoption by end users requiring precise cellular analysis. The ecosystem is shaped by regulatory frameworks, R&D collaboration, and the demand for advanced diagnostics and therapeutics.

Raw material suppliers — Sourcing biocompatible polymers, microfluidic components, and magnetic nanoparticles used in device fabrication

Technology providers — Developing proprietary separation techniques (e.g., microfluidics, acoustic sorting) for integration into commercial systems

OEMs — Manufacturing cell separation devices and consumables for clinical, research, and industrial applications

System integrators — Combining separation modules with automation, software, and data analytics for end-to-end solutions

Distributors — Channeling products to biopharma, diagnostics labs, and academic institutions through direct sales and reseller networks

End users — Biopharmaceutical companies, clinical diagnostic labs, and research institutions utilizing separation systems for cell-based therapies and analysis

Regulatory bodies — Governing product approvals, standardizing performance metrics, and ensuring compliance with safety protocols

Control points in the ecosystem are held by technology providers and regulators, who shape innovation pathways and market access. Dependency risks arise from raw material availability, regulatory delays, and interoperability challenges between separation modules and downstream analytics tools. Switching costs are influenced by system compatibility requirements and the need for validated workflows in highly regulated environments.

Recent Industry Insights

The cell separation technologies industry trends over the past 18 months reflect accelerated innovation driven by advancements in precision medicine and biopharma R&D. Strategic partnerships have dominated, with key players like Miltenyi Biotec collaborating with biotech firms to enhance automation in cell isolation workflows. The mergers & acquisitions landscape saw Thermo Fisher Scientific acquire a niche player in single-cell analysis, bolstering its portfolio in high-throughput solutions. Product launches highlighted a shift toward AI-integrated platforms, such as Beckman Coulter’s recent release of a machine-learning-enabled cell sorter. Regulatory updates, including the FDA’s revised guidelines on cell therapy manufacturing, have spurred demand for GMP-compliant separation systems. Enterprises are increasingly prioritizing automation and scalability, aligning with the rise of CAR-T therapies and regenerative medicine. Notably, startups in microfluidics and lab-on-a-chip technologies secured significant funding rounds, signaling investor confidence in miniaturized, high-precision tools. These trends underscore a market poised for exponential growth, with sustainability and digital integration emerging as critical differentiators.

Analyst Overview

The cell separation technologies market demonstrates strong market attractiveness, driven by advancements in cell therapy, regenerative medicine, and biopharmaceutical manufacturing. Rising demand for precision in clinical applications and the expansion of adoptive cell therapies, such as CAR-T, underscore its growth potential. Competitive intensity remains moderate, with established players focusing on R&D partnerships and niche startups innovating in automation and miniaturization. The long-term outlook is optimistic, supported by increasing adoption of single-cell analysis and favorable regulatory frameworks. However, innovation landscape challenges persist, as breakthroughs in AI-driven sorting and microfluidic systems face scalability hurdles. Demand–supply balance shows emerging regions lagging in infrastructure, creating opportunities for suppliers to bridge gaps. Key risk factors include high R&D costs, regulatory uncertainties, and supply chain vulnerabilities for critical components. Strategic investments in hybrid technologies and sustainability-driven solutions will define success in this evolving sector.

11 items

1. Executive Summary

2. cell separation technologies Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global cell separation technologies Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global cell separation technologies Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Oncology Research

6.1.2. Neuroscience Research

6.1.3. Stem Cell Research

6.1.4. Microbiology and Immunology Research

6.1.5. Others

6.2. Global cell separation technologies Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Gradient Centrifugation

6.2.2. Surface Markers Separation

6.2.3. Fluorescence Activated Cell Sorting

6.2.4. Magnetic Cell Sorting

6.2.5. Others

6.3. Global cell separation technologies Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global cell separation technologies Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global cell separation technologies Market by: Regions (Value)

8. Global cell separation technologies Market Competition by Key Manufacturers

8.1. Global cell separation technologies Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global cell separation technologies: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Miltenyi Biotec GmbH

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD Bioscience

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. STEMCELL Technologies

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo BCT

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. PluriSelect GmbH

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. EMD Millipore

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Life Technologies

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global cell separation technologies Market

Figure 4: Global cell separation technologies Market: Drivers

Figure 5: Global cell separation technologies Market: Challenges

Figure 6: Global cell separation technologies Market: Trends

Figure 7: Global cell separation technologies Market: Opportunity

Figure 8: Global cell separation technologies Market: Restraint

Figure 9: Global cell separation technologies Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global cell separation technologies Market Value (USD Million) By Region

Figure 15: Global cell separation technologies Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global cell separation technologies Market Value (USD Million) By Region

Figure 23: Global cell separation technologies Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global cell separation technologies Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global cell separation technologies Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global cell separation technologies Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global cell separation technologies Market Value (USD Million) By Region

Table 10: Global cell separation technologies Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global cell separation technologies Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global cell separation technologies Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global cell separation technologies Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Miltenyi Biotec GmbH Basic Information And Sales Area

Table 31: Miltenyi Biotec GmbH. Products Portfolio

Table 32: BD Bioscience Basic Information And Sales Area

Table 33: BD Bioscience. Products Portfolio

Table 34: STEMCELL Technologies Basic Information And Sales Area

Table 35: STEMCELL Technologies. Products Portfolio

Table 36: Terumo BCT Basic Information And Sales Area

Table 37: Terumo BCT. Products Portfolio

Table 38: PluriSelect GmbH Basic Information And Sales Area

Table 39: PluriSelect GmbH. Products Portfolio

Table 40: EMD Millipore Basic Information And Sales Area

Table 41: EMD Millipore. Products Portfolio

Table 42: Life Technologies Basic Information And Sales Area

Table 43: Life Technologies. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global cell separation technologies Market Value (USD Million) By Region

Table 49: Global cell separation technologies Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

cell separation technologies Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	3.16 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Miltenyi Biotec GmbH; BD Bioscience; STEMCELL Technologies; Terumo BCT; PluriSelect GmbH; EMD Millipore; Life Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options